Paclitaxel in ovarian cancer: how can we make it better?
Cannistra
S A
SA
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D017671:Platinum Compounds / Q000627:therapeutic use
D000970:Antineoplastic Agents; D017671:Platinum Compounds; D017239:Paclitaxel